Publication in peer-reviewed journal highlights RESPeRATE as effective hypertension treatment
Wednesday, April 22, 2009 - 08:42
in Health & Medicine
New York, N.Y.--April 22, 2009--InterCure Ltd., a medical device company publicly traded on the Tel-Aviv Stock Exchange (TASE: INCR), today announced that RESPeRATE--the only medical device cleared